- Weitere Titel
-
Chemoproteomische Charakterisierung kovalenter Proteinbindungen in Zellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2018
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Cells
Betrothal
Competition
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2018
- Urheber
-
Dittus, Lars
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20180924-1440290-1-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dittus, Lars
- Küster, Bernhard
- Pichlmair, Andreas
- Universitätsbibliothek der TU München
Entstanden
- 2018
Ähnliche Objekte (12)
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Functional characterization of Cereblon, the molecular target of immunomodulatory drugs
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Quantitative chemical proteomics for cancer characterization
Comprehensive characterization of the human proteome by multi-omic analyses
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
Studies on the functional domains in oncogenic JAK2 and identification of drug resistant mutations in FIP1L1-PDGFRa
A Systematical Analysis of the Signal Transduction Pathways Induced by the Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Functional characterization of Cereblon, the molecular target of immunomodulatory drugs
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Quantitative chemical proteomics for cancer characterization
Comprehensive characterization of the human proteome by multi-omic analyses
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
Studies on the functional domains in oncogenic JAK2 and identification of drug resistant mutations in FIP1L1-PDGFRa
A Systematical Analysis of the Signal Transduction Pathways Induced by the Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Functional characterization of Cereblon, the molecular target of immunomodulatory drugs
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Quantitative chemical proteomics for cancer characterization
Comprehensive characterization of the human proteome by multi-omic analyses
Pushing the boundaries of affinity-based target deconvolution: Promiscuous immobilization of nature-made molecules and proteome-wide medicinal chemistry
Chemical proteomics for characterization of small molecule kinase inhibitors in cancer and inflammation
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Identification of naturally presented HLA ligands on the surface of healthy and malignant hematopoetic cells and their therapeutic potential as targets for TCR-transgenic T cells
Studies on the functional domains in oncogenic JAK2 and identification of drug resistant mutations in FIP1L1-PDGFRa